Identifying effector molecules, cells, and cytokines of innate immunity in OA. 2020

M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
Experimental Rheumatology, Radboud University Medical Center, Nijmegen, the Netherlands.

Inflammatory changes are observed in affected joints of osteoarthritis (OA) patients and are thought to be involved in the pathology that develops along OA progression. This narrative review provides an overview of the various cell types that are present in the joint during OA and which alarmins, cytokines, chemokines, growth factors, and other mediators they produce. Moreover, the involvement of more systemic processes like inflammaging and its associated cellular senescence in the context of OA are discussed.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067531 Alarmins A structurally diverse group of endogenous molecules that are multifunctional, having physiological functions inside the cell, but when released from dying cells or from cells under stress or certain immune cells, they function to activate INNATE IMMUNITY. Uncontrolled and excessive release of alarmins may contribute to INFLAMMATION; CARCINOGENESIS, and NEOPLASM METASTASIS. Alarmins are also critical for heart and nerve tissue homeostasis. Alarmin,Alarmin Proteins,Damage-Associated Molecular Pattern Molecules,Danger-Associated Molecular Pattern Molecules,Damage Associated Molecular Pattern Molecules,Danger Associated Molecular Pattern Molecules
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016922 Cellular Senescence Process by which cells irreversibly stop dividing and enter a state of permanent growth arrest without undergoing CELL DEATH. Senescence can be induced by DNA DAMAGE or other cellular stresses, such as OXIDATIVE STRESS. Aging, Cell,Cell Aging,Cell Senescence,Replicative Senescence,Senescence, Cellular,Senescence, Replicative,Cell Ageing,Cellular Ageing,Cellular Aging,Ageing, Cell,Ageing, Cellular,Aging, Cellular,Senescence, Cell

Related Publications

M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
April 2006, Biochemical Society transactions,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
December 2000, Journal of leukocyte biology,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
October 2016, Immunology letters,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
January 2000, Reviews in immunogenetics,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
January 2001, Developmental and comparative immunology,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
September 2020, International journal of molecular sciences,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
October 1979, Immunology,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
June 2005, Current opinion in immunology,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
March 1992, Infection and immunity,
M H J van den Bosch, and P L E M van Lent, and P M van der Kraan
January 2010, Medecine sciences : M/S,
Copied contents to your clipboard!